We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Camtek Ltd | NASDAQ:CAMT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.06% | 84.37 | 83.03 | 84.49 | 84.89 | 83.13 | 83.40 | 543,397 | 00:32:36 |
CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
•
|
Revenues were a quarterly record at $40.1 million, up 23% year-over-year;
|
•
|
GAAP gross margin at 48.5%; Non-GAAP gross margin at 48.8%;
|
•
|
GAAP operating income was $6.3 million and non-GAAP operating income was $7.6 million, representing margins of 15.8% and 19.0%, respectively;
|
•
|
GAAP net income of $6.0 million, or $0.15 per diluted share, non-GAAP net income of $7.3 million, or $0.18 per diluted share; and
|
•
|
Operating cash flow of $5.0 million, with $106.0 million in net cash and short-term deposits at quarter-end.
|
US:
|
1 866 229 7198
|
at 9:00 am Eastern Time
|
Israel:
|
03 918 0609
|
at 3:00 pm Israel Time
|
International:
|
+972 3 918 0609
|
|
September 30,
|
December 31,
|
|||||||
2020
|
2019
|
|||||||
U.S. Dollars (In thousands)
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
26,042
|
38,047
|
||||||
Short-term deposits
|
80,000
|
51,500
|
||||||
Trade accounts receivable, net
|
33,747
|
31,443
|
||||||
Inventories
|
34,436
|
23,803
|
||||||
Other current assets
|
3,032
|
2,909
|
||||||
Total current assets
|
177,257
|
147,702
|
||||||
Fixed assets, net
|
18,886
|
18,526
|
||||||
Long term inventory
|
4,090
|
2,791
|
||||||
Deferred tax asset, net
|
8
|
746
|
||||||
Other assets, net
|
80
|
113
|
||||||
Intangible assets, net
|
619
|
491
|
||||||
4,797
|
4,141
|
|||||||
Total assets
|
200,940
|
170,369
|
||||||
Liabilities and shareholders’ equity
|
||||||||
Current liabilities
|
||||||||
Trade accounts payable
|
20,468
|
11,334
|
||||||
Other current liabilities
|
24,283
|
20,272
|
||||||
Total current liabilities
|
44,751
|
31,606
|
||||||
Long term liabilities
|
||||||||
Other long term liabilities
|
2,191
|
2,461
|
||||||
2,191
|
2,461
|
|||||||
Total liabilities
|
46,942
|
34,067
|
||||||
Commitments and contingencies
|
||||||||
Shareholders’ equity
|
||||||||
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2020 and at December 31, 2019;
|
||||||||
41,303,757 issued shares at September 30, 2019 and 40,742,355 at December 31, 2019;
|
||||||||
39,211,381 shares outstanding at September 30, 2020 and 38,649,979 at December 31, 2019
|
159
|
157
|
||||||
Additional paid-in capital
|
104,909
|
101,327
|
||||||
Retained earnings
|
50,828
|
36,716
|
||||||
155,896
|
138,200
|
|||||||
Treasury stock, at cost (2,092,376 as of September 30, 2020 and December 31, 2019)
|
(1,898
|
)
|
(1,898
|
)
|
||||
Total shareholders' equity
|
153,998
|
136,302
|
||||||
Total liabilities and shareholders' equity
|
200,940
|
170,369
|
Nine Months ended
September 30,
|
Three Months
ended September 30,
|
Year ended
December 31,
|
||||||||||||||||||
2020
|
2019
|
2020
|
2019
|
2019
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Revenues
|
107,240
|
100,818
|
40,061
|
32,470
|
134,019
|
|||||||||||||||
Cost of revenues
|
57,315
|
51,875
|
20,636
|
17,252
|
69,235
|
|||||||||||||||
Gross profit
|
49,925
|
48,943
|
19,425
|
15,218
|
64,784
|
|||||||||||||||
Research and development costs
|
13,952
|
11,891
|
5,068
|
4,164
|
16,331
|
|||||||||||||||
Selling, general and administrative expenses
|
21,374
|
19,668
|
8,036
|
6,681
|
26,481
|
|||||||||||||||
35,326
|
31,559
|
13,104
|
10,845
|
42,812
|
||||||||||||||||
Operating income
|
14,599
|
17,384
|
6,321
|
4,373
|
21,972
|
|||||||||||||||
Financial income, net
|
958
|
340
|
307
|
188
|
801
|
|||||||||||||||
Income from continuing operations
|
||||||||||||||||||||
before income taxes
|
15,557
|
17,724
|
6,628
|
4,561
|
22,773
|
|||||||||||||||
Income tax expense
|
(1,445
|
)
|
(1,508
|
)
|
(604
|
)
|
(398
|
)
|
(1,950
|
)
|
||||||||||
Net income from continuing operations
|
14,112
|
16,216
|
6,024
|
4,163
|
20,823
|
|||||||||||||||
Discontinued operations *
|
||||||||||||||||||||
Income from discontinued operations
|
||||||||||||||||||||
Income before tax expense
|
-
|
1,257
|
-
|
-
|
1,257
|
|||||||||||||||
Income tax expense
|
-
|
(94
|
)
|
-
|
-
|
(94
|
)
|
|||||||||||||
Net income from discontinued operations
|
-
|
1,163
|
-
|
-
|
1,163
|
|||||||||||||||
Net income
|
14,112
|
17,379
|
6,024
|
4,163
|
21,986
|
Nine months ended
September 30,
|
Three months
ended September 30,
|
Year ended
December 31,
|
||||||||||||||||||
2020
|
2019
|
2020
|
2019
|
2019
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Basic earnings from continuing operation
|
0.36
|
0.43
|
0.15
|
0.11
|
0.55
|
|||||||||||||||
Basic earnings from discontinued operation
|
-
|
0.03
|
-
|
-
|
0.03
|
|||||||||||||||
Basic net earnings
|
0.36
|
0.47
|
0.15
|
0.11
|
0.58
|
|||||||||||||||
Diluted earnings from continuing operation
|
0.35
|
0.43
|
0.15
|
0.11
|
0.54
|
|||||||||||||||
Diluted earnings from discontinued operation
|
-
|
0.03
|
-
|
-
|
0.03
|
|||||||||||||||
Diluted net earnings
|
0.35
|
0.46
|
0.15
|
0.11
|
0.57
|
|||||||||||||||
Weighted average number of ordinary shares outstanding (in thousands):
|
||||||||||||||||||||
|
||||||||||||||||||||
Basic
|
38,957
|
37,286
|
39,176
|
36,300
|
37,626
|
|||||||||||||||
Diluted
|
39,878
|
38,064
|
40,066
|
36,941
|
37,432
|
Nine Months ended
September 30,
|
Three Months ended
September 30,
|
Year ended
December 31,
|
||||||||||||||||||
2020
|
2019
|
2020
|
2019
|
2019
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Reported net income attributable to Camtek Ltd. on GAAP basis
|
14,112
|
17,379
|
6,024
|
4,163
|
21,986
|
|||||||||||||||
Share-based compensation
|
3,053
|
2,068
|
1,285
|
818
|
2,892
|
|||||||||||||||
Chroma transaction expenses (1)
|
-
|
136
|
-
|
63
|
136
|
|||||||||||||||
Attributable to discontinued operations
|
-
|
(1,163
|
)
|
-
|
-
|
(1,163
|
)
|
|||||||||||||
Non-GAAP net income
|
17,165
|
18,420
|
7,309
|
5,044
|
23,851
|
|||||||||||||||
Non–GAAP net income per diluted share
|
0.43
|
0.48
|
0.18
|
0.13
|
0.62
|
|||||||||||||||
Gross margin on GAAP basis from continuing operations
|
46.6
|
%
|
48.5
|
%
|
48.5
|
%
|
46.9
|
%
|
48.3
|
%
|
||||||||||
Reported gross profit on GAAP basis
|
49,925
|
48,943
|
19,425
|
15,218
|
64,784
|
|||||||||||||||
Share-based compensation
|
308
|
207
|
120
|
85
|
292
|
|||||||||||||||
Non- GAAP gross margin
|
50,233
|
49,150
|
19,545
|
15,303
|
65,076
|
|||||||||||||||
Non-GAAP gross profit
|
46.8
|
%
|
48.8
|
%
|
48.8
|
%
|
47.1
|
%
|
48.6
|
%
|
||||||||||
Reported operating income attributable to Camtek Ltd. on GAAP basis from continuing operations
|
14,599
|
17,384
|
6,321
|
4,373
|
21,972
|
|||||||||||||||
Share-based compensation
|
3,053
|
2,068
|
1,285
|
818
|
2,892
|
|||||||||||||||
Chroma transaction expenses (1)
|
-
|
136
|
-
|
63
|
136
|
|||||||||||||||
Non-GAAP operating income
|
17,652
|
19,588
|
7,606
|
5,254
|
25,000
|
(1)
|
In the second and third quarters of 2019, certain transaction expenses were incurred in relation to the technological cooperation agreement with Chroma. These were recorded under operating
expenses.
|
1 Year Camtek Chart |
1 Month Camtek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions